About David Clarence
David Clarence Doyle is an attorney licensed to practice regulation in California, holding the State Bar of California license number 70690. He used to be licensed to the State Bar on December 22, 1976, and is presently a companion at Morrison & Foerster LLP, an international law company known for its work in a number of sectors including life sciences.
Doyle earned his law degree from the University of California, Los Angeles (UCLA) School of Law in 1976. Prior to that, he obtained a Bachelor of Arts diploma from the University of California, San Diego in 1973. His educational background has provided a strong foundation for his legal career, particularly in the area of patent regulation.
His practice mainly focuses on patent litigation, particularly in the pharmaceutical and biotechnology industries. Doyle has represented generic drug companies in efforts to enter markets before competitors' exclusivity durations expire. Notably, he was involved in Sandoz Inc.'s efforts to invalidate patents held by Teva Pharmaceutical USA Inc. for its Copaxone drug, which generates meaningful revenue.
Throughout his profession, Doyle has treated various stages of legal proceedings, including legal proceedings, trials, appeals, bargaining sessions, and international arbitration. His experience as lead counsel in complicated patent infringement cases has based him as a knowledgeable figure in this legal field. He is usually eligible to practice in all California state courts and federal courts in the Ninth Circuit.
Doyle has received popularity for his contributions to patent litigation, including being named a Life Sciences MVP by Law360. He is an active member of the legal community and participates in a number of professional associations, further demonstrating his dedication to the sector of law and his involvement in network initiatives.
